Hansa Biopharma (Q3 Initial take): Sequential Sales Decline but Clinical Success
Igår, 08:22
Igår, 08:22
Redeye’s analyst just published a Research Note on Hansa Biopharma.
Click here to read the article
Make sure to add Hansa Biopharma to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.
Igår, 08:22
Redeye’s analyst just published a Research Note on Hansa Biopharma.
Click here to read the article
Make sure to add Hansa Biopharma to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.
Rapporter
Analyser

Rapporter
Analyser

1 DAG %
Senast

OMX Stockholm 30
1 DAG %
Senast
2 782,77